Company intelligence / Profile preview

Merz Real Estate and Financial Investments

Frankfurt am Main, Hesse, Germany

Ownership: Private
Development stage: Other

Overview

Merz Real Estate is an active private company within the broader Merz Group that focuses on real estate and investment activities rather than drug development or healthcare operations. It appears to function as a corporate investment and property-holding vehicle associated with the family-owned Merz organization in Frankfurt am Main, Germany. Publicly available evidence links it to real estate transactions and strategic shareholdings, including investment activity involving Noratis AG. Despite the user's likely life-science framing, this entity is not itself a biotech, pharma, or healthcare operating company and does not appear to have a therapeutic pipeline.

Industry: Investors

Partnerships

Noratis

Beyond the preview

Go deeper on Merz Real Estate and Financial Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merz Real Estate and Financial Investments.

Explore the full profile